Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
Kocer
B
B
Nazliel
B
B
Oztas
M
M
Batur
H Z
HZ
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011994:Recombinant Proteins; D012880:Skin Pigmentation / Q000187:drug effects; D014820:Vitiligo / Q000139:chemically induced*
D000276:Adjuvants, Immunologic; D007370:Interferon Type I; D011994:Recombinant Proteins; D016899:Interferon-beta; D000068556:Interferon beta-1a